세계의 인플루엔자 진단 시장 규모 조사 : 검사 유형별, 최종 용도별, 지역별 예측(2022-2032년)

Global Influenza Diagnostics Market is valued at approximately USD 1.63 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 5.78% over the forecast period 2024-2032. Influenza diagnostics refers to the methods and tools used to identify and diagnose influenza virus infections in individuals. These diagnostics play a crucial role in public health, allowing for early detection, treatment, and prevention of the spread of influenza. Also, the market was witnessing advancements in diagnostic technologies, particularly in the development of Rapid Diagnostic Tests (RDTs) and molecular diagnostics. These advancements aimed to improve the accuracy, sensitivity, and speed of influenza diagnosis which anticipated to support the growth of Influenza Diagnostics Market.

Moreover, increased awareness about the severity of influenza and its potential to cause outbreaks and pandemics has driven governments, healthcare organizations, and individuals to invest in diagnostic measures for timely detection and containment. Also, with the rise in the number of influenza cases globally, there is a growing demand for efficient and accurate diagnostic tests to identify and manage the infection. Additionally, other factors that support the market growth are the increasing geriatric population, growing demand for point-of-care testing, and cohesive government initiatives and funding. However, the lack of skilled professionals, and stringent regulatory frameworks are anticipated to hinder the market growth during the forecast period 2024-2032.

The key regions considered for the global Influenza Diagnostics market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, North America was the largest regional market. Increasing awareness among healthcare professionals and the general public about the importance of early diagnosis and treatment of influenza fuels the demand for diagnostic tests. Awareness campaigns by healthcare organizations and government bodies contribute to this trend. Also, North America has a significant healthcare expenditure budget, enabling healthcare facilities to invest in advanced diagnostic technologies. This financial capacity facilitates the adoption of innovative influenza diagnostic solutions. Whereas, the Asia Pacific is expected to grow with the highest CAGR during the forecast period 2024-2032.

Major market player included in this report are:

• 3M Company
• Abbott Laboratories
• Becton, Dickinson and Company (BD)
• Meridian Bioscience, Inc.
• Quidel Corporation
• F. Hoffmann-La Roche Ltd
• SA Scientific Ltd
• SEKISUI Diagnostics
• Thermo Fisher Scientific, Inc.
• Hologic, Inc.

The detailed segments and sub-segment of the market are explained below:

By Test Type

• RIDT
• RT-PCR
• Cell Culture
• Others

By End Use

• Hospitals
• POCT
• Laboratories

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• RoMEA

Years considered for the study are as follows:

• Historical year - 2022
• Base year - 2023
• Forecast period - 2024 to 2032

Key Takeaways:

• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market

Table of Contents

Chapter 1. Global Influenza Diagnostics Market Definition and Research Assumptions

• 1.1. Research Objective
• 1.2. Market Definition
• 1.3. Research Assumptions
  • 1.3.1. Inclusion & Exclusion
  • 1.3.2. Limitations
  • 1.3.3. Supply Side Analysis
    • 1.3.3.1. Availability
    • 1.3.3.2. Infrastructure
    • 1.3.3.3. Regulatory Environment
    • 1.3.3.4. Market Competition
    • 1.3.3.5. Economic Viability (Consumer's Perspective)
  • 1.3.4. Demand Side Analysis
    • 1.3.4.1. Regulatory frameworks
    • 1.3.4.2. Technological Advancements
    • 1.3.4.3. Environmental Considerations
    • 1.3.4.4. Consumer Awareness & Acceptance
• 1.4. Estimation Methodology
• 1.5. Years Considered for the Study
• 1.6. Currency Conversion Rates

Chapter 2. Executive Summary

• 2.1. Global Influenza Diagnostics Market Size & Forecast (2022- 2032)
• 2.2. Regional Summary
• 2.3. Segmental Summary
  • 2.3.1. By Test Type
  • 2.3.2. By End Use
• 2.4. Key Trends
• 2.5. Recession Impact
• 2.6. Analyst Recommendation & Conclusion

Chapter 3. Global Influenza Diagnostics Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Challenges
• 3.3. Market Opportunities

Chapter 4. Global Influenza Diagnostics Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
  • 4.1.6. Futuristic Approach to Porter's 5 Force Model
  • 4.1.7. Porter's 5 Force Impact Analysis
• 4.2. PESTEL Analysis
  • 4.2.1. Political
  • 4.2.2. Economical
  • 4.2.3. Social
  • 4.2.4. Technological
  • 4.2.5. Environmental
  • 4.2.6. Legal
• 4.3. Top investment opportunity
• 4.4. Top winning strategies
• 4.5. Disruptive Trends
• 4.6. Industry Expert Perspective
• 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Influenza Diagnostics Market Size & Forecasts by Test Type 2022-2032

• 5.1. RIDT
• 5.2. RT-PCR
• 5.3. Cell Culture
• 5.4. Others

Chapter 6. Global Influenza Diagnostics Market Size & Forecasts by End Use 2022-2032

• 6.1. Hospitals
• 6.2. POCT
• 6.3. Laboratories

Chapter 7. Global Influenza Diagnostics Market Size & Forecasts by Region 2022-2032

• 7.1. North America Influenza Diagnostics Market
  • 7.1.1. U.S. Influenza Diagnostics Market
    • 7.1.1.1. Test Type breakdown size & forecasts, 2022-2032
    • 7.1.1.2. End Use breakdown size & forecasts, 2022-2032
  • 7.1.2. Canada Influenza Diagnostics Market
• 7.2. Europe Influenza Diagnostics Market
  • 7.2.1. U.K. Influenza Diagnostics Market
  • 7.2.2. Germany Influenza Diagnostics Market
  • 7.2.3. France Influenza Diagnostics Market
  • 7.2.4. Spain Influenza Diagnostics Market
  • 7.2.5. Italy Influenza Diagnostics Market
  • 7.2.6. Rest of Europe Influenza Diagnostics Market
• 7.3. Asia-Pacific Influenza Diagnostics Market
  • 7.3.1. China Influenza Diagnostics Market
  • 7.3.2. India Influenza Diagnostics Market
  • 7.3.3. Japan Influenza Diagnostics Market
  • 7.3.4. Australia Influenza Diagnostics Market
  • 7.3.5. South Korea Influenza Diagnostics Market
  • 7.3.6. Rest of Asia Pacific Influenza Diagnostics Market
• 7.4. Latin America Influenza Diagnostics Market
  • 7.4.1. Brazil Influenza Diagnostics Market
  • 7.4.2. Mexico Influenza Diagnostics Market
  • 7.4.3. Rest of Latin America Influenza Diagnostics Market
• 7.5. Middle East & Africa Influenza Diagnostics Market
  • 7.5.1. Saudi Arabia Influenza Diagnostics Market
  • 7.5.2. South Africa Influenza Diagnostics Market
  • 7.5.3. Rest of Middle East & Africa Influenza Diagnostics Market

Chapter 8. Competitive Intelligence

• 8.1. Key Company SWOT Analysis
• 8.2. Top Market Strategies
• 8.3. Company Profiles
  • 8.3.1. 3M Company
    • 8.3.1.1. Key Information
    • 8.3.1.2. Overview
    • 8.3.1.3. Financial (Subject to Data Availability)
    • 8.3.1.4. Product Summary
    • 8.3.1.5. Market Strategies
  • 8.3.2. Abbott Laboratories
  • 8.3.3. Becton, Dickinson and Company (BD)
  • 8.3.4. Meridian Bioscience, Inc.
  • 8.3.5. Quidel Corporation
  • 8.3.6. F. Hoffmann-La Roche Ltd
  • 8.3.7. SA Scientific Ltd
  • 8.3.8. SEKISUI Diagnostics
  • 8.3.9. Thermo Fisher Scientific, Inc.
  • 8.3.10. Hologic, Inc.

Chapter 9. Research Process

• 9.1. Research Process
  • 9.1.1. Data Mining
  • 9.1.2. Analysis
  • 9.1.3. Market Estimation
  • 9.1.4. Validation
  • 9.1.5. Publishing
• 9.2. Research Attributes